Evidence map›Paper›PMID 37876736›Full record

ArticleSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2023

Interferon-λ3 rs12979860 can regulate inflammatory cytokines production in pulmonary fibrosis.

Eman Hamdi, Amany A Bekhit, Aliaa Higazi, Abo Bakr F Ahmed, Ahmed Hussein Kasem, Mustafa A M Najim, Thamir M Alshammari, Khaled Thabet

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Eman HamdiDepartment of Biochemistry, Faculty of Pharmacy, Minia University, Minia 61519, Egypt.
Amany A BekhitDepartment of Biochemistry, Faculty of Pharmacy, Minia University, Minia 61519, Egypt.
Aliaa HigaziDepartment of Clinical Pathology, Faculty of Medicine, Minia University, Minia 61519, Egypt.
Abo Bakr F AhmedDepartment of Microbiology and Immunology, Faculty of Pharmacy, Minia University, Minia 61519, Egypt.
Ahmed Hussein KasemDepartment of Chest Diseases, Faculty of Medicine, Minia University, Minia 61519, Egypt.
Mustafa A M NajimDepartment of Medical Laboratories Technology, Faculty of Applied Medical Sciences, Taibah University, Medina, Saudi Arabia.
Thamir M AlshammariMedication Safety Research Chair, King Saud University, Riyadh, Saudi Arabia.
Khaled ThabetDepartment of Biochemistry, Faculty of Pharmacy, Minia University, Minia 61519, Egypt.
Minia University · EGAlfaisal University · SATaibah University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary fibrosis (PF) is the last phase of interstitial lung diseases (ILDs), which are a collection of pulmonary illnesses marked by parenchymal remodeling and scarring. Treatment can only halt the functional decline of the lung, raising the necessity of identifying the basic processes implicated in lung fibrogenesis. The Interferon lambda-3 (

Indexed as

CTD-ILDInterferon lambda-3 (IFN-λ3)Interstitial lung diseasesIPFLung fibrosis

Identifiers

PMID37876736
PMCPMC10590737
OpenAlexW4387398606

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.